by Anand Patadiya | Feb 25, 2025
Dr. Gulley is an internationally recognized expert in cancer immunotherapy with a strong interest in prostate cancer. Since 1998 he has authored and run a variety of clinical trials at the National Cancer Institute. These innovative, investigator-initiated studies...
by Anand Patadiya | Feb 25, 2025
As Chief of the Laboratory of Tumor Immunology and Biology, Dr. Schlom directs a translational research program in cancer immunology and immunotherapy. He has pioneered the use of novel immunotherapeutics, both as monotherapy and in combination therapies, for a range...
